Post by Xaira Therapeutics

"There is a scaling law, very excitingly, and it’s really this combination of more data, diverse data, and an appropriate architecture that together provide an important foundation for the path forward.” Our CEO Marc Tessier-Lavigne shared more details around the launch of our first virtual cell model, X-Cell, with Andrew Dunn from Endpoints News. X-Cell is already making predictions on two cell types not included in the model’s training data — and we are excited to see the technology supercharge our core mission: delivering life-saving medicines to patients in need. Full article here: https://lnkd.in/eY-jd8qz